ExAdEx-Innov to participate at the 35th IFSCC Congress in Cannes

ExAdEx-Innov to participate at the 35th IFSCC Congress in Cannes

EXADEX-INNOV will be participating in the 35th IFSCC Congress, the world’s premier cosmetic science congress, taking place in Cannes from September 15–18, 2025

 
VISIT US AT BOOTH 14bis

Join us at Booth 14bis to discover our latest advancements in cosmetic science.
We’ll be showcasing our brand-new models, innovative research tools, and state-of-the-art 3D imaging techniques. Whether you’re an industry expert, a passionate researcher, or simply curious about the future of skincare, our team is eager to connect and discuss how our scientific solutions can elevate your projects.

POSTER HIGHLIGHTS

Don’t miss our latest research breakthroughs, presented in two exciting posters:

  • Poster #1278 – Distinct Body Site-Specific Profiles in 3D-Cultured Human Donor Hypodermis-Derived Models: Implications for Targeted Skincare Product Development – Explore next-level targeted skincare with our innovative 3D-cultured models.
  • Poster #1274 – First 3D Facial Hypodermis Donor-Derived Tissue Model for holistic assessment and mechanistic evaluation of dermocosmetic ingredients – Discover a new era for holistic dermocosmetic ingredient evaluation.

Let’s Connect in Cannes!

 

📅 IFSCC 2025 Congress

WHEN: September 15-18, 2025
WHERE:  Cannes (France)
SESSION:  NEW TOOLS & SERVICES
BOOTH: 14bis

Facebook
LinkedIn

Latest News

KOL on adipose tissue biology.

Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice). 

Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program). 

Co-inventor of 5 patents

Expert in clinical applications of adipose tissue.

Plastic Reconstructive and Aesthetic Surgeon in Nice.

Member of the Medical Council of Alpes Maritimes region.

Expert for the French National Regulatory Agency ANSM for medical devices.

Certified by French Health Autority HAS (2020-2024).

PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.

Expert in cell therapy and immunology. 

Senior Lecturer (Maitre de conférences).

Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).

Director of « Micoralis » research team at Université Côte d’Azur (Nice).

Founder and CEO of the biotech company Biointerférence (2003-2006).

Co-inventor of 5 patents.

Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.

With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov. 

In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille). 

He is co-inventor of the 2 company’s patent families. 

Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue. 

Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.

With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years. 

He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.

Main areas of expertise: Biotech Startup Business Development; Project management